The global Sales of equine diagnostic services was valued at around US$ 165 Mn in 2019, and is projected to witness steady growth of approximately 5% through 2030.
The impact of the COVID-19 outbreak on the short-term prospects of the industry is likely to be moderate. Concerns over transmission between veterinary professionals and clients is creating operational challenges for equine vet practices, and reducing cash flow for market players as non-urgent cases are postponed. Participants in the equine diagnostic services market are pushing strategies involving product development and launches in addition to strategic acquisitions to bolster portfolios and production capacities in a fairly competitive sector.
However, the coronavirus pandemic is also likely to generate growth opportunities in terms of telemedicine, and from growing awareness about equine coronavirus among horse owners, which are likely to contribute to the sector in the long term. Furthermore, higher interest in diagnostic standardization with ISO parameters and investments in technologies for MRI devices and full body scans are expected to aid the growth of the equine diagnostic services market for years to come.
“Growing interest in equine sports in Asia Pacific, rising incidence of zoonotic ailments, and demand for insurance coupled with steady growth in the number of veterinary professionals are expected to support the rise of the equine diagnostic services market,”says a Fact.MR analyst.
Key Takeaways from Equine Diagnostic Services Market Report
- North America is a leading regional market, driven largely by a prominent equine sporting and leisure industry, and higher spending for veterinary diagnostics and treatment, in addition to investments in genomic testing in the region.
- Hospital and clinics are the primary source for diagnostic services associated with equine ailments, supported by easier access to technologies such as MRIs and full body scans.
- Lab and mobile testing are driving the equine diagnostic services market, supported by rising access to technical expertise for advanced diagnostics, including molecular assays.
- Diagnostics for equine trypanosomosis will remain important for market developments, particularly in terms of prophylactic drug development for better clinical outcomes.
- The COVID-19 pandemic is expected to have a moderate effect on the global equine diagnostic services market in the short term.
Global Equine Diagnostic Services Market: Segmentation
Service Type
- Genetic Testing
- Phenotype Testing
- Infectious Disease Testing
- Others
Service Setting
- Hospitals & Clinics
- Lab Testing & Mobile Settings
Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5229
Following Questions Answers Covered in the Report are:
- How will the global Equine Diagnostic Services Market perform during the forecast period? What will be the market size in terms of value and volume?
- Which segment will drive the global Equine Diagnostic Services Market? Which regional market will show extensive growth in the future? What are the reasons?
- How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
- What are the key strategies adopted by players to sustain themselves in the global Equine Diagnostic Services Market?
- How will these strategies influence the market growth and competition?
Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5229
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
- Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)
Product Development and Strategic Acquisitions – Critical to Growth
Prominent players in the equine diagnostic services market such as Generatio GmbH, Equiseq Inc., VetGen, Animal Genetics Inc., Veterinary Genetics Laboratory, Etalon Inc., and IDEXX Laboratories Inc. are largely emphasizing on product and service development associated with equine ailments, and strategic acquisitions and collaborations to invest in geographic and capacity expansion. For instance,
- Zoetis Inc. announced the acquisition of Phoenix Central Laboratory for Veterinarians with the aim of providing point of care diagnostic testing for full spectrum analysis, including equine, feline, canine, and avian health requirements.
- Equine Biotech, in collaboration with the Indian Institute of Science, has developed an RT-PCR kit to trace the presence of SARS-CoV-2 in equine patient samples, which requires amplification and reverse transcription processes in real time.
These factors are expected to be major contributors to market revenue and service improvements, particularly with MRIs and full body scans gaining traction in a fairly competitive market landscape, for years to come.
More Insights on Equine Diagnostic Services Market
In a new report, Fact.MR has provided readers with a detailed analysis about the equine diagnostic services market, with essential data on historic demand (2015 to 2019) and forecasting information for the period of 2020 and 2030. The report gives readers of the equine diagnostic services market report insights in terms of service type (genetic testing, phenotype testing, infectious disease testing, and others) and service setting (hospitals & clinics and lab testing and mobile settings), across key regions around the world (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Jumeirah Lakes Towers,
